DNA RNA and Cells

05 Apr 2007 Genta Appeals FDA Decision on Genasense in CLL
31 Mar 2007 LCT reports major step forward for islet transplantation in diabetes patient
27 Mar 2007 Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients Presented at ACC
26 Mar 2007 Osiris Therapeutics Announces Positive Results in Groundbreaking Stem Cell Trial to Treat Heart Disease
24 Mar 2007 Genta Announces Expectation of a Negative Opinion from the CHMP on Genasense(R) Application for Advanced Melanoma
23 Mar 2007 Pain Therapeutics Licenses Biotechnology To Treat Rare Disorder
21 Mar 2007 La Jolla Pharmaceutical Company (LJPC) Provides Update on Interim Antibody Results From Riquent(R) Lupus Phase 3 Trial
20 Mar 2007 Pervasis Therapeutics Launches Enrollment for Two Phase II Clinical Trials for Vascugel(TM)
15 Mar 2007 Transgene: First Patients Included in TG 1042 (Ad-IFNg) Phase II Clinical Trial in Cutaneous B-Cell Lymphoma
14 Mar 2007 Enzo Therapeutics Treats First Patient in Phase I/II Study of Antisense Gene Therapy for HIV-1 Infections
09 Mar 2007 TOPIGEN Initiates Expanded Phase II Trial of Inhaled TPI ASM8 in Patients With Asthma
09 Mar 2007 La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent Lupus Phase 3 Trial
07 Mar 2007 ProNAi and Novosom AG Announce Collaboration to Enable Delivery of DNAi-based Cancer Therapeutics
02 Mar 2007 AVI BioPharma Presents Novel HIV Drug Candidate Results
01 Mar 2007 IDM Pharma Announces the Completion of Enrollment in Two Phase II Trials of Uvidem(R) in Melanoma
01 Mar 2007 Amsterdam Molecular Therapeutics BV receives global rights to develop and commercialize AMT-020 for acute intermittent porphyria
24 Feb 2007 Phase 2 Results of Genasense(R) Plus Chemotherapy in Advanced Prostate Cancer Reported at Cancer Conference
21 Feb 2007 Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
20 Feb 2007 Skin graft substitute (ICX-SKN) commences Phase I
15 Feb 2007 Aastrom's U.S. Clinical Investigator to Report Interim Data on Long Bone Fracture Repair Trial
15 Feb 2007 BrainStorm Cell Therapeutics Initiates Stem Cell Safety Study in Primates for Parkinson's Disease
14 Feb 2007 Neuralstem Inc. Cells Survive and Become Neurons in Rats With Spinal Injuries, Study Reports
14 Feb 2007 Osiris Announces Top-Line Interim Results for Stem Cell Trial for Knee Repair
13 Feb 2007 Targeted Genetics Provides Inflammatory Arthritis Clinical Trial Update
09 Feb 2007 Pluristem Announces US FDA Acceptance of its Pre-IND Application to begin Pre-clinical Studies using PLX- I in Hematological Malignancies

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up